Cancer BiologybioRxivPreprint
Transcriptional landscape of DTP-DTEP transition reveals DUSP6 as a driver of HER2 inhibitor tolerance via Neuregulin/HER3 axis
M. Momeny, M. Tienhaara, D. Chakroborty…·J. Westermarck
This study identifies DUSP6 as a driver of HER2 inhibitor tolerance through the Neuregulin/HER3 axis by analyzing the transcriptional changes during the DTP-DTEP transition in HER2+ breast cancer cells.
DOI 10.1101/2023.06.14.544493